Tricarico, P., Chardin, D., Martin, N., Contu, S., Hugonnet, F., Otto, J., Humbert, O.

Purpose
Because of atypical response imaging patterns in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICPIs), new biomarkers are needed for a better monitoring of treatment efficacy. The aim of…